- Xerox Holdings Corp XRX reported a third-quarter FY21 sales decline of 0.5% year-on-year, to $1.76 billion, missing the analyst consensus of $1.81 billion.
- Equipment sales declined 7.6%, while Post sale revenue improved 1.7%.
- Sales in the Americas declined 2.2% Y/Y, and EMEA rose 4.6%.
- The gross margin contracted 440 basis points Y/Y to 32.4%. The adjusted operating margin shrank 320 basis points to 4.2%, and the adjusted operating income for the quarter declined 43.5% to $74 million.
- Xerox held $2.2 billion in cash and equivalents as of September 30, 2021. Operating cash flow amounted to $100 million, and free cash flow totaled $81 million in the quarter.
- EPS of $0.48 beat the analyst consensus of $0.44.
- Xerox said that the Delta variant caused delays in many of their clients' plans to return employees to the workplace.
- The company's board approved an additional $500 million share repurchase program.
- Outlook: Xerox reduced FY21 revenue guidance to $7.1 billion in actual currency and $7.0 billion in constant currency, versus the consensus of $7.26 billion.
- Price Action: XRX shares are trading lower by 7.54% at $19.02 on the last check Tuesday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in